Metabolic Health and Hormone Balance With Chiropractic Care

Metabolic Health and Hormone Balance With Chiropractic: An Evidence-Based Guide From Clinic to Daily Life

Abstract

In this educational post, I, Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, synthesize current evidence and clinical insights to help you navigate complex hormone concerns across the lifespan, including perimenopause and menopause symptoms, postmenopausal bleeding, testosterone optimization, dizziness and low energy in older adults, recurrent infections, and the interplay of gut, brain, and endocrine function. I explain the physiological underpinnings of hormone signaling, the immune-endocrine network, and how metabolic and lifestyle inputs shape outcomes. I also share practical decision trees for discontinuing combined oral contraceptives, managing abnormal uterine bleeding, addressing UTI differentials, counseling on ADHD and anxiety from a gut-brain perspective, and calibrating expectations for pellet-based therapies. Throughout, I highlight how integrative chiropractic care interfaces with functional medicine—leveraging neuromusculoskeletal assessment, autonomic regulation, and movement-based rehabilitation to improve sleep, stress resilience, motility, and pain, thereby enhancing endocrine balance.

Hormones, Health, and The Two-Week Mindset: Structuring Care With Clear Timelines

One recurrent theme I stress in clinical practice is the value of clearly defined care windows. When I say “we will focus intensively for two weeks,” it is not arbitrary. Short, high-adherence windows improve engagement, reduce overwhelm, and allow me to reassess biomarkers and symptoms in a controlled manner.

• Why two-week intervals can work:
  • Behavioral adherence: Patients are more likely to comply with specific goals than with vague, open-ended timelines.
  • Physiological sampling: Many endocrine and autonomic markers (sleep, HRV, resting heart rate, bowel transit, morning energy) can meaningfully shift across two weeks of consistent inputs.
  • Iteration: Short cycles allow me to pivot—adjust dosing, timing, or delivery route—before adverse patterns consolidate.

I anchor these windows to specific tasks: nutrition patterns, sleep-wake timing, structured movement, stress tools, and precise medication or supplement protocols. And I circle back with planful follow-ups rather than drifting into indefinite therapy. This phased approach mirrors adaptive multi-omics care models, in which rapid feedback loops improve outcomes (Topol, 2019).

The Neuroendocrine Baseline: Why Symptoms Fluctuate With Stress, Sleep, and Movement

Patients often ask why symptoms appear “out of nowhere.” The answer is that nothing in biology truly arrives unannounced—the nervous, immune, and endocrine systems are constantly cross-talking.

• The HPA axis and autonomic tone:
  • The hypothalamic-pituitary-adrenal (HPA) axis coordinates cortisol rhythms. Poor sleep, chronic stress, and inflammation dampen cortisol’s diurnal slope, raise evening arousal, and disrupt gonadotropin signals, altering estrogen, progesterone, and testosterone patterns (Adam et al., 2017).
  • The autonomic nervous system (ANS) links posture, pain, and visceral function. Increased sympathetic tone can slow gut motility, affect pelvic floor function, and modulate immune responses (Tracey, 2002).
• Chiropractic integration:
  • Gentle, targeted spinal manipulation and soft-tissue work can lower pain signaling and sympathetic overactivity, improving HRV and sleep quality. By improving thoracic mobility and diaphragmatic mechanics, we enhance vagal input, which supports motility and inflammatory control—both key to hormone balance and gut-brain function (Martínez-Segura et al., 2012; Pascoal-Faria et al., 2022).

Perimenopause, Menopause, and Postmenopausal Bleeding: Physiology, Workups, and Practical Protocols

Perimenopause is a dynamic oscillation of hormone signals rather than a linear decline. The ovaries can intermittently “kick back in,” producing peaks of estradiol amid otherwise low output. This volatility creates the classic “high-low” symptom pattern: hot flashes, sleep disruption, mood variability, and unpredictable bleeding.

• The physiology:
  • Erratic ovarian follicle recruitment changes estradiol and progesterone levels, while pituitary FSH fluctuates as feedback loops recalibrate (Harlow et al., 2012).
  • Estradiol swings affect mast cell activity, thermoregulation, and vascular reactivity. Progesterone fluctuations alter GABAergic tone, sleep consolidation, and gut motility.
• When to investigate bleeding:
  • Any postmenopausal bleeding (≥12 months since last period) warrants evaluation for endometrial pathology—polyps, hyperplasia, or malignancy (ACOG, 2018).
  • Common pathway: history and pelvic exam, transvaginal ultrasound (TVUS to assess endometrial thickness), and targeted endometrial sampling if TVUS is abnormal or bleeding persists.
  • Interventional options reported in practice include hysteroscopic polypectomy and uterine artery embolization for select fibroids, often allowing safe resumption of tailored hormone therapy when pathology is addressed.
• Why are progestogens used?
  • Progesterone stabilizes the endometrium and counterbalances estradiol-driven proliferation, thereby reducing the risk of bleeding with estrogen therapy (Stuenkel et al., 2015).
  • Micronized progesterone supports sleep and anxiety reduction through GABA-A modulation, a clinically relevant benefit in perimenopause.
• Clinical observations:
  • In my clinic, I have seen patients with previously unrecognized fibroids respond well to interventional radiology procedures and then maintain stable symptom control with individualized hormone programs. When I titrate progesterone, I do so based on end-organ responses: sleep quality, breast tenderness, and bleeding patterns.
• Integrative chiropractic fit:
  • Thoracolumbar mobility and pelvic alignment can influence pelvic floor tone and venous return. Manual therapy and guided breathing reduce pelvic congestion and improve exercise tolerance, which together may lessen cycle-related pain and improve adherence to lifestyle plans.

The Decision Tree for Discontinuing Combined Oral Contraceptives

In patients using combined oral contraceptives (COCs) long term, we carefully weigh clotting risks (DVT, PE, stroke), migraine with aura, smoking status, and cardiovascular history. COCs increase sex hormone-binding globulin (SHBG), potentially lowering free testosterone and contributing to low energy, low libido, and mood changes in susceptible individuals ( Zimmerman et al., 2014).

• My approach:
  • If risks outweigh benefits, I will educate the patient on why we will transition. I discuss non-estrogen options (progestin-only IUDs and copper IUDs) and non-hormonal strategies.
  • If heavy withdrawal bleeds have occurred historically, replete iron; assess thyroid status based on symptoms and risk factors; and monitor ferritin, B12, and vitamin D to facilitate a smooth transition.
  • Chiropractic and movement plans target posture, core stability, and breathing mechanics to support autonomic balance as the endocrine system recalibrates.

Testosterone Optimization: Context, Dosing, and Safety

Testosterone therapy is not a one-number game; it is a network intervention. I focus on symptoms, free testosterone, estradiol via aromatization, hematocrit, lipids, liver enzymes, and fertility goals.

• Physiology and reasoning:
  • Testosterone influences erythropoiesis, neuromuscular drive, mitochondria, and mood. Supraphysiologic peaks from certain delivery systems can cause transient fluid shifts, sleep fragmentation, or blood pressure changes in sensitive individuals (Corona et al., 2020).
  • I favor steady-state delivery methods when symptom peaks coincide with large trough-to-peak swings. I re-evaluate after approximately 6–8 weeks, then quarterly once stable.
• Fertility considerations:
  • Exogenous testosterone suppresses LH/FSH and spermatogenesis. Human chorionic gonadotropin (hCG) can maintain intratesticular testosterone levels, but responses vary, and costs can be high (Patel et al., 2019). I counsel candidly, review semen analyses, and tailor timelines.
• Dizziness and low energy in older adults:
  • In an 85-year-old with dizziness and low vitality, I prioritize cardiovascular, neurologic, and medication reviews, orthostatic vitals, and anemia/thyroid screening before attributing symptoms to testosterone. I do not “chase” a single lab; rather, I correct reversible contributors, consider cautious low-dose trials when indicated, and monitor function and safety.
• Integrative chiropractic fit:
  • Cervicogenic dizziness and autonomic dysregulation can be addressed with cervical/thoracic mobility, vestibular drills, and breathing retraining. These interventions often improve energy and balance while endocrine strategies take effect.

Gut-Brain-Endocrine Axis: ADHD, Anxiety, and Motility

I routinely assess the gut-brain axis in patients with ADHD or anxiety. The enteric nervous system, microbiome metabolites, and vagal tone modulate inflammation, neurotransmitter precursors, and steroid hormone metabolism.

• Why the gut matters:
  • Dysbiosis shifts short-chain fatty acid and bile acid profiles, altering intestinal permeability and systemic inflammation, which feed back into neuroendocrine circuits (Cryan et al., 2019).
  • Progesterone and estradiol influence motility; progesterone tends to slow transit, which may modulate absorption and symptom timing.
• My protocol considerations:
  • Diet: fiber-rich, polyphenol-dense, protein-adequate nutrition timed to circadian rhythm.
  • Sleep: regular sleep-wake anchors to stabilize the HPA axis and catecholamines.
  • Targeted probiotics and prebiotics based on symptoms; cautious with agents that could worsen bloating until motility is regulated.
  • Chiropractic: thoracolumbar adjustments, rib mobilization, and diaphragm work to enhance vagal tone and abdominal mechanics.

Recurrent Infections and Differential Thinking: UTI, Skin Flora, and Antibiotic Stewardship

When evaluating urinary tract symptoms, I avoid reflexively treating for organisms not typically implicated. Group A Streptococcus is an uncommon urinary pathogen in adults; I reserve therapy for organisms confirmed by culture and clinical context (Nicolle, 2019).

• If history includes recurrent staph skin infections:
  • That history alone does not preclude the use of tricyclics such as amitriptyline (Elavil) for pain modulation when indicated. I screen for QT risk, anticholinergic burden, and interactions. For recurrent skin infections, I consider decolonization strategies, skin barrier care, and glycemic control.
• Why this matters:
  • Antibiotic overuse disrupts the microbiome, increases resistance, and can worsen genitourinary symptoms through estrogen-microbiome-urogenital cross-talk.

Postmenopausal Bleeding and Structural Pathology: When Progesterone Isn’t Enough

Sometimes escalating progestin dosing does not stop bleeding because the primary problem is structural—polyp, fibroid, or hyperplasia. This is why we pair symptom protocols with imaging.

• Evidence-based steps:
  • TVUS to evaluate endometrial thickness and focal lesions.
  • Hysteroscopy for direct visualization and polypectomy.
  • Uterine artery embolization for appropriate fibroid cases often preserves the option to continue individualized hormone therapy.
• Clinical example:
  • I have cared for patients who regained symptom control and quality of life after appropriately addressing a uterine polyp or fibroid, subsequently stabilizing on hormone therapy with careful follow-up and clear education on red-flag symptoms.

Iodine, Halides, and Thyroid: What the Evidence Actually Says

Iodine is essential for thyroid hormone synthesis; however, excess iodine can precipitate dysfunction in susceptible individuals. Claims that iodine universally “detoxes halides” or that insufficiency directly causes widespread cancers do not reflect consensus evidence.

• Physiology and balance:
  • The thyroid requires iodine to produce T4 and T3. Both deficiency and excess can cause goiter or thyroiditis (Zimmermann & Boelaert, 2015).
  • I assess dietary intake, regional water sources, autoimmune markers, and use of iodine-containing supplements. I adjust carefully—neither deprivation nor megadosing.
• Integrative chiropractic fit:
  • Stress reduction and improved sleep through neuromusculoskeletal care can modulate HPA and sympathetic nervous system activity, which often interact with thyroid symptomatology.

Pellet Therapies, Peaks and Troughs, and Patient Expectations

Some patients experience transient symptoms several weeks after pellet insertion, potentially related to peak levels or individualized sensitivity. I prepare patients for this possibility and schedule check-ins.

• Why peaks matter:
  • Rapid hormonal rises can influence fluid balance, thermoregulation, and sleep. Monitoring levels and correlating with symptom diaries helps determine whether to adjust dose, interval, or delivery method.
• Strategic supports:
  • Hydration, electrolyte balance, sleep hygiene, resistance and aerobic training, and autonomic-calming techniques from chiropractic care can blunt peak-related discomfort.
• Motility concerns:
  • If progesterone slows transit and alters medication absorption timing, I may adjust dosing time, use divided doses, or change route. I focus on fiber, hydration, and abdominal breathing to optimize motility.

Sex Steroids, SHBG, and Energy: Understanding “Why I Feel Off”

I educate patients that total hormone values are only part of the story. SHBG rises with oral estrogens, lowering free testosterone; insulin resistance and thyroid status also affect SHBG.

• Practical implications:
  • If free testosterone is low with high SHBG, I may transition away from oral estrogens, emphasize resistance training, ensure adequate protein intake, and optimize thyroid function and insulin sensitivity.
  • Chiropractic-guided movement prescriptions improve muscle insulin sensitivity and mitochondrial function, synergizing with endocrine care.

Thrombotic Risk, Age, and Contraceptives: Matching the Tool to the Patient

A patient in her late 40s with cardiovascular stents, migraine with aura, or thrombophilia risks is generally not a candidate for estrogen-containing pills. I emphasize safer alternatives and explain the “why” to empower decision-making.

• My reasoning:
  • Estrogen increases clot risk in a dose-dependent manner and interacts with lifestyle and genetics. Non-estrogen options reduce risk without sacrificing reliable contraception.

DHEA, Saw Palmetto, and Prostate Considerations

For men with lower urinary tract symptoms or suspected dihydrotestosterone (DHT)-driven prostate issues, saw palmetto has mixed evidence but may provide modest benefit in select cases when combined with lifestyle and pelvic floor strategies (Tacklind et al., 2012). In women, androgen-modulating strategies are individualized; I avoid one-size-fits-all supplementation.

• Chiropractic fit:
  • Pelvic floor coordination and lumbar mechanics can meaningfully improve urinary symptoms independent of pharmacology, adding a low-risk, high-value modality.

Communication, Counseling, and “Second Opinion” Culture

Honest, early communication is therapeutic. When I suspect a serious condition, I encourage a structured second opinion and provide a clear summary for the consulting specialist. This reduces panic, accelerates correct diagnosis, and honors patient autonomy.

• For genetic counseling:
  • I prepare patients with family histories, a medication list, and specific questions about reproductive planning and cancer risk management. I contextualize metabolic panel results within the broader clinical picture to avoid overemphasizing inconclusive single values.

AI and Clinical Workflows: Precision Without Noise

Artificial intelligence is changing how we practice, but tools must be paired with clinical judgment. I use decision support for drug interactions, structured symptom diaries, and pattern recognition—not as a replacement for the hands-on exam, history, and individualized assessment.

• The value:
  • AI helps flag outliers and visualize trends. Our job is translating those patterns into safe, humane, context-aware care plans.

How Integrative Chiropractic Care Amplifies Outcomes

Integrative chiropractic care is a pillar in my approach because neuromusculoskeletal alignment and autonomic regulation influence nearly every endocrine complaint.

• Mechanistic pathways:
  • Pain relief reduces sympathetic arousal, decreasing HPA axis strain.
  • Thoracic mobility and diaphragmatic breathing improve vagal tone, GI motility, and sleep architecture.
  • Posture optimization reduces upper airway collapsibility during sleep, which may reduce snoring and improve oxygenation—vital for hormonal and cognitive health.
  • Movement prescriptions support bone density, insulin sensitivity, and mitochondrial function, synergizing with hormone therapy to improve lean mass and mood.
• Clinical outcomes from my practice:
  • Patients who combine targeted chiropractic sessions with nutrition, sleep timing, and personalized hormone protocols frequently report better energy, calmer mood, fewer vasomotor symptoms, and improved adherence to rehab. I have observed positive changes in HRV and functional balance testing that correlate with improvements in symptoms.

Putting It All Together: A Simple Process You Can Follow

• Step 1: Clarify goals and timelines.
  • Define a two-week focus period with precise actions and metrics.
• Step 2: Check the basics.
  • Sleep, breathing, hydration, protein intake, fiber, and daily movement.
• Step 3: Make diagnostics count.
  • Target labs and imaging to the question at hand; do not overtest without a plan to act.
• Step 4: Match therapy to physiology.
  • Choose hormone delivery routes and doses that align with symptoms, comorbidities, and patient preferences; anticipate peaks and adjust accordingly.
• Step 5: Integrate chiropractic care.
  • Use spinal and rib mobility, soft tissue techniques, and breathing retraining to optimize autonomic balance and pain control.
• Step 6: Reassess and iterate.
  • Repeat symptom inventories, adjust doses, revisit movement progression, and refine sleep and nutrition strategies every 2–8 weeks.
• Step 7: Educate and empower.
  • Encourage informed second opinions when the stakes are high; provide clear summaries and avoid fear-based narratives.

Clinical Pearls and Cautions

• Any bleeding after 12 months of amenorrhea warrants evaluation.
• Testosterone therapy requires fertility counseling; do not assume hCG will preserve sperm without testing.
• Do not overtreat UTIs without culture evidence; antibiotic stewardship preserves the microbiome.
• Beware of simplistic “detox” narratives; apply iodine prudently and personalize thyroid care.
• Expect variability during perimenopause; communicate that oscillations are part of the process while still addressing red flags.

Final Word

My goal is to translate complex physiology into actionable steps that respect your biology and your life. By combining modern, evidence-based hormone strategies with integrative chiropractic care, movement, and smart diagnostics, we can help you feel better, think clearer, and live stronger—without guesswork. If this resonates, we can design a focused two-week plan, measure what matters, and iterate together.

---

References

• Adam, E. K., Quinn, M. E., Tavernier, R., McQuillan, M. T., Dahlke, K. A., & Gilbert, K. E. (2017). Diurnal cortisol slopes and mental and physical health outcomes: A systematic review and meta-analysis. Psychoneuroendocrinology, 83, 25–41. https://doi.org/10.1016/j.psyneuen.2017.05.018
• American College of Obstetricians and Gynecologists. (2018). The role of transvaginal ultrasonography in evaluating the endometrium of women with postmenopausal bleeding. Obstetrics & Gynecology, 131(5), e124–e129. https://doi.org/10.1097/AOG.0000000000002631
• Corona, G., Goulis, D. G., Huhtaniemi, I., Zitzmann, M., Toppari, J., Forti, G., & Maggi, M. (2020). European Academy of Andrology (EAA) guidelines on investigation, treatment and monitoring of functional hypogonadism in males. Andrology, 8(5), 970–987. https://doi.org/10.1111/andr.12770
• Cryan, J. F., O’Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., … Dinan, T. G. (2019). The microbiota-gut-brain axis. Physiological Reviews, 99(4), 1877–2013. https://doi.org/10.1152/physrev.00018.2018
• Harlow, S. D., Gass, M., Hall, J. E., Lobo, R., Maki, P., Rebar, R. W., … STRAW+10 Collaborative Group. (2012). Executive summary of the Stages of Reproductive Aging Workshop +10. Menopause, 19(4), 387–395. https://doi.org/10.1097/gme.0b013e31824d8f40
• Martínez-Segura, R., De-La-Llave-Rincón, A. I., Ortega-Santiago, R., Cleland, J. A., Fernández-de-las-Peñas, C., & Plaza-Manzano, G. (2012). Immediate changes in cervical range of motion and pain after spinal manipulation in patients with acute neck pain. Clinical Journal of Pain, 28(7), 615–621. https://doi.org/10.1097/AJP.0b013e31823ae8e5
• Nicolle, L. E. (2019). Uncomplicated urinary tract infection in adults, including uncomplicated pyelonephritis. Urologic Clinics of North America, 46(2), 1–12. https://doi.org/10.1016/j.ucl.2018.12.004
• Pascoal-Faria, P., Lopes, P., & Ferreira, J. J. (2022). Vagus nerve, autonomic nervous system, and pain: A neurophysiological perspective. Clinical Neurophysiology Practice, 7, 157–165. https://doi.org/10.1016/j.cnp.2022.05.003
• Patel, A. S., Leong, J. Y., Ramos, L., & Ramasamy, R. (2019). Testosterone is a contraceptive and should not be used in men who desire fertility. World Journal of Men’s Health, 37(1), 45–54. https://doi.org/10.5534/wjmh.180036
• Stuenkel, C. A., Davis, S. R., Gompel, A., Lumsden, M. A., Murad, M. H., Pinkerton, J. V., & Santen, R. J. (2015). Treatment of symptoms of the menopause: An endocrine society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism, 100(11), 3975–4011. https://doi.org/10.1210/jc.2015-2236
• Tacklind, J., MacDonald, R., Rutks, I., Stanke, J. U., & Wilt, T. J. (2012). Serenoa repens for benign prostatic hyperplasia. Cochrane Database of Systematic Reviews, 12, CD001423. https://doi.org/10.1002/14651858.CD001423.pub3
• Topol, E. (2019). High-performance medicine: The convergence of human and artificial intelligence. Nature Medicine, 25(1), 44–56. https://doi.org/10.1038/s41591-018-0300-7
• Zimmermann, M. B., & Boelaert, K. (2015). Iodine deficiency and thyroid disorders. Lancet Diabetes & Endocrinology, 3(4), 286–295. https://doi.org/10.1016/S2213-8587(14)70225-6
• Zimmerman, Y., Eijkemans, M. J. C., Coelingh Bennink, H. J. T., Blankenstein, M. A., & Fauser, B. C. J. M. (2014). The effect of combined oral contraception on testosterone levels in healthy women. Journal of Clinical Endocrinology & Metabolism, 99(6), 2064–2072. https://doi.org/10.1210/jc.2013-3894